ClinVar Miner

Submissions for variant NM_006009.4(TUBA1A):c.1169G>C (p.Arg390Pro) (rs1064796460)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Broad Institute Rare Disease Group,Broad Institute RCV000770768 SCV000924565 likely pathogenic Lissencephaly 3 2018-06-15 criteria provided, single submitter research The heterozygous p.Arg390Pro variant was identified by our study in one individual with lissencephaly. This variant was absent from large population studies. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, supporting that a change at this position may not be tolerated. Other variants at this position, all de novo, have been reported pathogenic in the literature, supporting the likelihood that this is a pathogenic variant (Poirier et al. 2013, PMID: 20466733; Kumar et al. 2010, PMID: 22948023; Zanni et al. 2013, PMID: 23317684). In summary, although additional studies are required to fully establish its pathogenicity, this variant is likely pathogenic.
Department of Pediatrics,Driscoll Children's Hospital RCV000770768 SCV000852008 pathogenic Lissencephaly 3 criteria provided, single submitter clinical testing The Arg390Pro mutation in TUBA1A gene reported in our study is associated with a broader clinical phenotype than previously reported. The cerebral dysgenesis includes severe lissencephaly, polymicrogyria, and agenesis of both the corpus callosum and cerebellum. The extra-cranial manifestations of cleft palate and optic nerve hypoplasia have not been previously reported. This single amino acid substitution of a positively charged arginine with a neutrally-charged proline strongly suggests a change in the protein configuration and function of tubulin which resulted in altered function of microtubules that are crucial in normal neuronal migration and cerebral development.
GeneDx RCV000486649 SCV000573195 pathogenic not provided 2017-11-21 criteria provided, single submitter clinical testing The R390P variant in the TUBA1A gene has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. However, different missense variants at the same position (R390C, R390H) have been reported as de novo variants in individuals with TUBA1A-related disorders (Kumar et al., 2010; Poirier et al., 2013; Zanni et al., 2013). The R390P variant is not observed in large population cohorts (Lek et al., 2016). The R390P variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In-silico analyses, including protein predictors and evolutionary conservation, are inconsistent in their assessment as to whether or not the variant is damaging. Targeted parental testing results indicate this variant was apparently de novo in a patient tested at GeneDx.
Institute of Human Genetics,Friedrich-Alexander-Universität Erlangen-Nürnberg RCV000767439 SCV000898054 likely pathogenic Tubulinopathies 2018-07-01 criteria provided, single submitter literature only A variant that is classified as likely pathogenic has been identified in the TUBA1A gene in a born individual of unknown sex. The c.1169G>C, p.(Arg390Pro) variant has been reported as a variant of germline/unknown origin.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.